BLACKMORES yesterday released
details of its financial performance
for the nine months to 31 Mar, with
group sales of $241m up a healthy
29% compared to the previous
corresponding period.
However net profit after tax slid
7% to $18.5 million “as a result
of pressures in a challenging
Australian retail environment,”
according to ceo Christine Holgate.
She said the strong sales result
was a reflection of the continuing
transformation of the business.
Local sales are up 7% but the third
quarter figures “were impacted
by larger retail accounts reducing
stock levels,” Holgate said.
“Additionally, profits have come
under pressure by heavy price
promotions and higher than normal
stock write-offs due to structural
changes within the Australian
market,” she added.
The BioCeuticals division achieved
8% sales growth “and continues to
contribute to Group profitability”.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Apr 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Apr 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.